Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons. [electronic resource]
- Experimental neurology Sep 2013
- 663-72 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1090-2430
10.1016/j.expneurol.2013.03.002 doi
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine--pharmacology Adrenergic Agents--toxicity Analysis of Variance Animals Apomorphine--pharmacology Corpus Striatum--drug effects Disease Models, Animal Dopamine Agonists--pharmacology Dynorphins--metabolism Early Growth Response Protein 1--genetics Enkephalins--genetics Functional Laterality--drug effects Gene Expression Regulation--drug effects Male Motor Neurons Movement--physiology Oxidopamine--toxicity Parkinson Disease--etiology RNA, Messenger Rats Rats, Sprague-Dawley